Low Total Testosterone-Component of Metabolic Syndrome

Open access

Abstract

Background and aims: To assess the levels of total testosterone in the metabolic syndrome patients.

Material and Methods: We included ninety-six patients in our study, forty-nine with metabolic syndrome according to the definition of International Diabetes Federation (IDF) and forty-seven as control. Anthropometric measurements were registered and blood samples were taken after an overnight fast.

Results: The mean values of different parameters showed significant differences between both groups. The total testosterone mean value was (338,97±91,2 ng/ml) substantially lower as compared to patients with metabolic syndrome to control group.

Conclusion: There is an inverse relationship between total testosterone and metabolic syndrome. Low total testosterone can be a predictor of rising incidence of metabolic syndrome.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Haller H. Epidermiology and associated risk factors of hyperlipoproteinemia Z Gesamte Inn Med 32(8): 124–28 1977

  • 2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease". Diabetes 37(12): 1595–607 1988

  • 3. Travison TG Araujo AB O’Donnell AB Kupelian V McKnlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92(1): 196-202 2007

  • 4. Lopez DS Canfield S Wang R. Testosterone replacement therapy and the heart: friend foe or bystander? Transl Androl Urol 5(6):898-9082016

  • 5. Lopez DS Advani S Tsilidis KK Wang R Canfield S. Endogenous and exogenous testosterone and prostate cancer: decreased increased or null-risk? Transl Androl Urol. 6(3): 566-579 2017

  • 6. Bjorntorp P. Endocrine abnormalities in obesity. Diabetes Rev 5: 52-68 1997

  • 7. Laaksonen DE Niskanen L Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5):1036-1041 2004

  • 8. Kolovou GD Anagnostopoulou KK Salpea KD Mikhailidis DP. The prevalence of metabolic syndrome in various populations Am J Med Sci 333(6): 362-71 2007

  • 9. Qabulio SN Akhtar S Ziauddin F Khan W Afridi SA. Prevalence of the Metabolic Syndrome in Low Socio-Economic Urban Population. ISRA Medical JournalVolume 10(5): 291-295 2018

  • 10. Alberti KGMM Eckel RH Grundy SM et al. Harmonizing the metabolic syndrome: a joint statement of the international diabetes federation task force on epidemiology and prevention; National heart lung and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity. Circulation 120(16): 1640-1645 2009

  • 11. Laaksonen DE Niskanen L Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5): 1036-41 2004

  • 12. Kupelian V Page ST Araujo AB et al. Low sex hormone-binding globulin total testosterone and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men J Clin Endocrinol Metab 91(3): 843-850 2006

  • 13. Kapoor D Malkin CJ Channer KS Jones TH. Androgens insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63(3): 239-50 2005.

Search
Journal information
Impact Factor


CiteScore 2018: 0.19

SCImago Journal Rank (SJR) 2018: 0.128
Source Normalized Impact per Paper (SNIP) 2018: 0.229

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 77 77 20
PDF Downloads 43 43 8